Cycurion, Inc.
For the period ended Sep 30, 2025. Filed Nov 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 14, 2025
CYCU$2.470.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
| For the Nine Months Ended | ||
|---|---|---|
| September 30, 2025 | September 30, 2024 | |
| Cash flows from operating activities: | ||
| Net (loss)/income | $(18,778,917) | $109,712 |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Stock-based compensation | 3,094,443 | 10,000 |
| Stock-based compensation - business combination related | 9,521,734 | - |
| Amortization of debt discount | 234,430 | - |
| Depreciation of property and equipment | 20,321 | 6,590 |
| Amortization of software development costs | 25,000 | - |
| Gain on debt settlement, net | (1,250,139) | - |
| Finance expense | 100,000 | - |
| Changes in assets and liabilities: | ||
| Accounts receivable, net and other receivables | (286,701) | (1,921,546) |
| Prepaid expenses and other current assets | 42,326 | 2,403 |
| Accounts payable and accrued liabilities | (1,494,416) | 627,256 |
| Net cash used in operating activities | (8,771,919) | (1,165,585) |
| Cash flows from investing activities: | ||
| Cash acquired on business combination | 34,983 | - |
| Issuance of promissory notes | - | (354,000) |
| Purchase of property and equipment | (268,000) | (343,001) |
| Cash withdrawn from Trust Account in connection with redemption | 1,001,216 | - |
| Release of Trust Account to Company’s bank account | 833,324 | - |
| Net cash provided by/(used in) investing activities | 1,601,523 | (697,001) |
| Cash flows from financing activities: | ||
| Proceeds from exercise of warrants | 3,664,871 | - |
| Redemption of common stock subject to redemption | (1,001,216) | - |
| Proceeds from private placement | - | 1,000,000 |
| Proceeds from capital raise | 5,874,584 | - |
| Net proceeds from line of credit | (18,000) | 106,924 |
| Repayment of bank borrowings | (499,180) | (6,503) |
| Proceeds from convertible notes payable | 2,376,500 | - |
| Proceeds from notes payable | 513,200 | 215,000 |
| Proceeds from notes payable - related parties | - | 15,000 |
| Repayments of notes payable - related parties | (27,500) | - |
| Repayments of notes payable | (101,579) | - |
| Net cash provided by financing activities | 10,781,680 | 1,330,421 |
| Net increase/(decrease) in cash and cash equivalents | 3,611,284 | (532,165) |
| Cash and cash equivalents, beginning of period | 40,790 | 607,869 |
| Cash and cash equivalents, end of period | $3,652,074 | $75,704 |
| See accompanying notes to unaudited financial statements | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.